These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15110533

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.
    Richardson J, Moraillon A, Crespeau F, Baud S, Sonigo P, Pancino G.
    J Virol; 1998 Mar; 72(3):2406-15. PubMed ID: 9499101
    [Abstract] [Full Text] [Related]

  • 7. Most potential linear B cell epitopes of Env glycoproteins of feline immunodeficiency virus are immunogenically silent in infected cats.
    Massi C, Lombardi S, Indino E, Matteucci D, La Rosa C, Esposito F, Garzelli C, Bendinelli M.
    AIDS Res Hum Retroviruses; 1997 Sep 01; 13(13):1121-9. PubMed ID: 9282817
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
    Kusuhara H, Hohdatsu T, Seta T, Nemoto K, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H.
    Vet Microbiol; 2007 Mar 10; 120(3-4):217-25. PubMed ID: 17141431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antiviral activity of membrane fusion inhibitors that target gp40 of the feline immunodeficiency virus envelope protein.
    Mizukoshi F, Baba K, Goto Y, Setoguchi A, Fujino Y, Ohno K, Oishi S, Kodera Y, Fujii N, Tsujimoto H.
    Vet Microbiol; 2009 Apr 14; 136(1-2):155-9. PubMed ID: 19036536
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies.
    Bull ME, Vahlenkamp TW, Dow JL, Collisson EW, Winslow BJ, Phadke AP, Tompkins MB, Tompkins WA.
    Vet Immunol Immunopathol; 2004 May 14; 99(1-2):25-37. PubMed ID: 15113651
    [Abstract] [Full Text] [Related]

  • 17. Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope.
    Richardson J, Fossati I, Moraillon A, Castelot S, Sonigo P, Pancino G.
    J Gen Virol; 1996 Apr 14; 77 ( Pt 4)():759-71. PubMed ID: 8627265
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins.
    Avrameas A, Strosberg AD, Moraillon A, Sonigo P, Pancino G.
    Res Virol; 1993 Apr 14; 144(3):209-18. PubMed ID: 7689247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.